Insights of rheumatoid arthritis biomarkers

References

• Aggarwal, R., et al., 2009. Anti-citrullinated peptide antibody assays and their role in the diagnosis of rheumatoid arthritis. Arthritis and rheumatism, 61 (11), 1472–1483.
   PubMedGoogle Scholar
• Aletaha, D., Alasti, F., and Smolen, J.S., 2015. Rheumatoid factor, not antibodies against citrullinated proteins, is associated with baseline disease activity in rheumatoid arthritis clinical trials. Arthritis research and therapy, 17, 229–239.
   Web of Science ®Google Scholar
• Aletaha, D., et al., 2010. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Annals of the rheumatic diseases, 69 (9), 1580–1588.
   PubMed Web of Science ®Google Scholar
• Amulic, B., et al., 2012. Neutrophil function: from mechanisms to disease. Annual review of immunology, 30, 459–489.
   PubMed Web of Science ®Google Scholar
• Andrade, F., et al., 2010. Autocitrullination of human peptidyl arginine deiminase type 4 regulates protein citrullination during cell activation. Arthritis and rheumatism, 62 (6), 1630–1640.
   PubMedGoogle Scholar
• Baka, Z., et al., 2012. Citrullination under physiological and pathological conditions. Joint bone spine, 79 (5), 431–436.
   PubMed Web of Science ®Google Scholar
• Bang, H., et al., 2012. Carbamoylation of vimentin in patients with rheumatoid arthritis: identification of a novel protein modification with a possible link to disease pathogenesis. Arthritis and rheumatology, 63, 685.
   Google Scholar
• Biomarkers definitions working group. 2001. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework.Clinical pharmacology & therapeutics, 69, 89–95.
   PubMed Web of Science ®Google Scholar
• Brink, M., et al., 2015. Anti-carbamylated protein antibodies in the pre-symptomatic phase of rheumatoid arthritis, their relationship with multiple anti-citrulline peptide antibodies and association with radiological damage. Arthritis research & therapy, 17 (1), 25.
   PubMedGoogle Scholar
• Bruschi, M., et al., 2017. Post-translational modified proteins are biomarkers of autoimmune-processes: NETosis and the inflammatory-autoimmunity connection. Clinica chimica acta, 464, 12–16.
   PubMed Web of Science ®Google Scholar
• Burska, A.N., et al., 2014. Autoantibodies to posttranslational modifications in rheumatoid arthritis. Mediators of inflammation, 2014, 492873.
   PubMed Web of Science ®Google Scholar
• Carubbi, F., et al., 2019. Post-translational modifications of proteins: novel insights in the autoimmune response in rheumatoid arthritis. Cells, 8 (7), 657.
   Web of Science ®Google Scholar
• Challener, G.J., et al., 2016. Anti-carbamylated protein antibody levels correlate with anti-sa (citrullinated vimentin) antibody levels in rheumatoid arthritis. Journal of rheumatology, 43 (2), 273–281.
   PubMed Web of Science ®Google Scholar
• Chang, H.-H., et al., 2015. The W620 polymorphism in PTPN22 disrupts its interaction with peptidylarginine deiminase type 4 and enhances citrullination and NETosis. Arthritis & rheumatology, 67 (9), 2323–2334.
   PubMed Web of Science ®Google Scholar
• Chang, H.-H., et al., 2012. PTPN22.6, a dominant negative isoform of PTPN22 and potential biomarker of rheumatoid arthritis. Plos one, 7 (3), e33067.
   PubMed Web of Science ®Google Scholar
• Claxton, J.S., et al., 2013. Endogenous carbamylation of renal medullary proteins. PLoS ONE, 8 (12), e82655.
   PubMed Web of Science ®Google Scholar
• Conigliaro, P., et al., 2016. Autoantibodies in inflammatory arthritis. Autoimmunity reviews, 15 (7), 673–683.
   PubMed Web of Science ®Google Scholar
• Corsiero, E., et al., 2016. NETosis as source of autoantigens in rheumatoid arthritis. Frontiers in immunology, 7, 485.
   PubMed Web of Science ®Google Scholar
• Croft, A.P., et al., 2019. Distinct fibroblast subsets drive inflammation and damage in arthritis. Nature, 570 (7760), 246–251.
   PubMed Web of Science ®Google Scholar
• Darrah, E., et al., 2013. Erosive rheumatoid arthritis is associated with antibodies that activate PAD4 by increasing calcium sensitivity. Science translational medicine, 5 (186), 186ra65.
   PubMed Web of Science ®Google Scholar
• Di Ruscio, A., et al., 2013. DNMT1-interacting RNAs block gene-specific DNA methylation. Nature, 503 (7476), 371–376.
   PubMed Web of Science ®Google Scholar
• Dörner, T., et al., 2004. Rheumatoid factor revisited. Current opinion in rheumatology, 16 (3), 246–253.
   PubMed Web of Science ®Google Scholar
• Drinda, S., et al., 2002. Identification of the advanced glycation end products N(epsilon)-carboxymethyllysine in the synovial tissue of patients with rheumatoid arthritis. Annals of the rheumatic diseases, 61 (6), 488–492.
   PubMed Web of Science ®Google Scholar
• Duroux-Richard, I., et al., 2014. Circulating miRNA-125b is a potential biomarker predicting response to rituximab in rheumatoid arthritis. Mediators of inflammation, 2014, 342524.
   PubMed Web of Science ®Google Scholar
• Eggleton, P., et al., 2013. Detection and isolation of human serum autoantibodies that recognize oxidatively modified autoantigens. Free radical biology and medicine, 57, 79–91.
   PubMed Web of Science ®Google Scholar
• England, B.R., et al., 2019. Malondialdehyde-acetaldehyde adducts and antibody responses in rheumatoid arthritis-associated interstitial lung disease. Arthritis & rheumatology, 71 (9), 1483–1493.
   PubMed Web of Science ®Google Scholar
• Fehr, T., et al., 1997. Role of repetitive antigen patterns for induction of antibodies against antibodies. Journal of experimental medicine, 185 (10), 1785–1792.
   PubMed Web of Science ®Google Scholar
• Filková, M., et al., 2014. Association of circulating miR-223 and miR-16 with disease activity in patients with early rheumatoid arthritis. Annals of the rheumatic diseases, 73 (10), 1898–1904.
   PubMed Web of Science ®Google Scholar
• Firestein, G.S., 2017. Etiology and pathogenesis of rheumatoid arthritis. In: G.S. Firestein, R.C. Budd, S.E. Gabriel, I.B. McInnes, J.R. O’Dell, eds. Kelley and Firestein’s Textbook of Rheumatology. 10 ed. Philadelphia: Elsevier, pp. 1115–1166.e7.
   Google Scholar
• Gabarrini, G., et al., 2015. The peptidylarginine deiminase gene is a conserved feature of Porphyromonas gingivalis. Scientific reports, 5, 13936–13938.
   PubMed Web of Science ®Google Scholar
• Gardette, A., et al., 2014. High anti-CCP antibody titres predict good response to rituximab in patients with active rheumatoid arthritis. Joint bone spine, 81 (5), 416–420.
   PubMed Web of Science ®Google Scholar
• Ge, C., and Holmdahl, R., 2019. The structure, specificity and function of anti-citrullinated protein antibodies. Nature reviews. Rheumatology, 15 (8), 503–508.
   PubMed Web of Science ®Google Scholar
• Goëb, V., et al., 2009. Diagnostic and prognostic usefulness of antibodies to citrullinated peptides. Joint bone spine, 76 (4), 343–349.
   PubMed Web of Science ®Google Scholar
• Gottenberg, J.E., et al., 2016. Brief report: association of rheumatoid factor and anti-citrullinated protein antibody positivity with better effectiveness of abatacept: results from the pan-european registry analysis. Arthritis & rheumatology, 68 (6), 1346–1352.
   PubMed Web of Science ®Google Scholar
• Gregersen, P.K., et al., 2006. PTPN22: setting thresholds for autoimmunity. Seminars in immunology, 18 (4), 214–223.
   PubMed Web of Science ®Google Scholar
• Hafkenscheid, L., et al., 2017. Structural analysis of variable domain glycosylation of anti-citrullinated protein antibodies in rheumatoid arthritis reveals the presence of highly sialylated glycans. Molecular & cellular proteomics, 16 (2), 278–287.
   PubMed Web of Science ®Google Scholar
• Hafkenscheid, L., et al., 2019. N-linked glycans in the variable domain of igg anti–citrullinated protein antibodies predict the development of rheumatoid arthritis. Arthritis & rheumatology, 71 (10), 1626–1633.
   PubMed Web of Science ®Google Scholar
• Hair, M.J.H., et al., 2014. Features of the synovium of individuals at risk of developing rheumatoid arthritis: implications for understanding preclinical rheumatoid arthritis. Arthritis & rheumatology, 66 (3), 513–522.
   PubMedGoogle Scholar
• Halvorsen, E.H., et al., 2009. Serum IgG antibodies to peptidylarginine deiminase 4 predict radiographic progression in patients with rheumatoid arthritis treated with tumour necrosis factor-alpha blocking agents. Annals of the rheumatic diseases, 68 (2), 249–252.
   PubMed Web of Science ®Google Scholar
• Han, B., et al., 2014. Fine mapping seronegative and seropositive rheumatoid arthritis to shared and distinct HLA alleles by adjusting for the effects of heterogeneity. American journal of human genetics, 94 (4), 522–532.
   PubMed Web of Science ®Google Scholar
• Hitchon, C.A., and El-Gabalawy, H.S., 2004. Oxidation in rheumatoid arthritis. Arthritis research & therapy, 6 (6), 265–278.
   PubMed Web of Science ®Google Scholar
• Huizinga, T.W.J., et al., 2005. Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA-DRB1 shared epitope for antibodies to citrullinated proteins. Arthritis & rheumatism, 52 (11), 3433–3438.
   PubMedGoogle Scholar
• Humphreys, J.H., et al., 2016. Anticarbamylated protein antibodies are associated with long-term disability and increased disease activity in patients with early inflammatory arthritis: results from the Norfolk Arthritis Register. Annals of the rheumatic diseases, 75 (6), 1139–1144.
   PubMed Web of Science ®Google Scholar
• Jaisson, S., and Gillery, P., 2010. Evaluation of nonenzymatic posttranslational modification-derived products as biomarkers of molecular aging of proteins. Clinical chemistry, 56 (9), 1401–1412.
   PubMed Web of Science ®Google Scholar
• Jaisson, S., et al., 2007. Carbamylation differentially alters type I collagen sensitivity to various collagenases. Matrix biology, 26 (3), 190–196.
   PubMed Web of Science ®Google Scholar
• Janssen, K.M.J., et al., 2017. Autoantibodies against citrullinated histone H3 in rheumatoid arthritis and periodontitis patients. Journal of clinical periodontology, 44 (6), 577–584.
   PubMed Web of Science ®Google Scholar
• Jiang, X., et al., 2014. Anti-CarP antibodies in two large cohorts of patients with rheumatoid arthritis and their relationship to genetic risk factors, cigarette smoking and other autoantibodies. Annals of the rheumatic diseases, 73 (10), 1761–1768.
   PubMed Web of Science ®Google Scholar
• Joseph, R., et al., 2013. Association between chronic periodontitis and rheumatoid arthritis: a hospital-based case–control study. Rheumatology international, 33 (1), 103–109.
   PubMed Web of Science ®Google Scholar
• Kaur, S., White, S., and Bartold, P.M., 2013. Periodontal disease and rheumatoid arthritis: a systematic review. Journal of dental research, 92 (5), 399–408.
   PubMed Web of Science ®Google Scholar
• Khan, F. and Siddiqui, A.A., 2006. Prevalence of anti-3-nitrotyrosine antibodies in the joint synovial fluid of patients with rheumatoid arthritis, osteoarthritis and systemic lupus erythematosus. Clinica chimica acta, 370 (1-2), 100–107.
   PubMed Web of Science ®Google Scholar
• Kolarz, B., and Majdan, M., 2017. Epigenetic aspects of rheumatoid arthritis: contribution of non-coding RNAs. Seminars in arthritis and rheumatism, 46 (6), 724–731.
   PubMed Web of Science ®Google Scholar
• Kolfenbach, J.R., et al., 2010. Autoimmunity to peptidyl arginine deiminase type 4 precedes clinical onset of rheumatoid arthritis. Arthritis and rheumatism, 62 (9), 2633–2639.
   PubMedGoogle Scholar
• Konig, M.F., et al., 2016. Aggregatibacter actinomycetemcomitans-induced hypercitrullination links periodontal infection to autoimmunity in rheumatoid arthritis. Science translational medicine, 8 (369), 369ra176.
   PubMed Web of Science ®Google Scholar
• Koziel, J., Mydel, P., and Potempa, J., 2014. The link between periodontal disease and rheumatoid arthritis: an updated review. Current rheumatology reports, 16 (3), 408.
   PubMed Web of Science ®Google Scholar
• Krintel, S.B., et al., 2016. Prediction of treatment response to adalimumab: a double-blind placebo-controlled study of circulating microRNA in patients with early rheumatoid arthritis. Pharmacogenomics journal, 16 (2), 141–146.
   PubMed Web of Science ®Google Scholar
• Kurowska, W., et al., 2017. The role of anti-citrullinated protein antibodies (ACPA) in the pathogenesis of rheumatoid arthritis. Central-European journal of immunology, 42 (4), 390–398.
   PubMed Web of Science ®Google Scholar
• Leshner, M., et al., 2012. PAD4 mediated histone hypercitrullination induces heterochromatin decondensation and chromatin unfolding to form neutrophil extracellular trap-like structures. Frontiers in immunology, 3, 307.
   PubMed Web of Science ®Google Scholar
• Lewis, H.D., et al., 2015. Inhibition of PAD4 activity is sufficient to disrupt mouse and human NET formation. Nature chemical biology, 11 (3), 189–191.
   PubMed Web of Science ®Google Scholar
• Li, Z., et al., 2018. Long non-coding RNAs in rheumatoid arthritis. Cell proliferation, 51 (1), e12404.
   Web of Science ®Google Scholar
• Li, P., et al., 2010. PAD4 is essential for antibacterial innate immunity mediated by neutrophil extracellular traps. Journal of experimental medicine, 207 (9), 1853–1862.
   PubMed Web of Science ®Google Scholar
• Luime, J.J., et al., 2010. Does anti-mutated citrullinated vimentin have additional value as a serological marker in the diagnostic and prognostic investigation of patients with rheumatoid arthritis? A systematic review. Annals of the rheumatic diseases, 69 (2), 337–344.
   PubMed Web of Science ®Google Scholar
• Lundberg, K., et al., 2008. Antibodies to citrullinated α-enolase peptide 1 are specific for rheumatoid arthritis and cross-react with bacterial enolase. Arthritis & rheumatism, 58 (10), 3009–3019.
   PubMedGoogle Scholar
• Mastrangelo, A., et al., 2015. The role of posttranslational protein modifications in rheumatological diseases: focus on rheumatoid arthritis. Journal of immunology research, 2015, 712490.
   PubMed Web of Science ®Google Scholar
• Matsumoto, A., et al., 2017. MTORC1 and muscle regeneration are regulated by the LINC00961-encoded SPAR polypeptide. Nature, 541 (7636), 228–232.
   PubMed Web of Science ®Google Scholar
• Matuszewska, A., Madej, M., and Wiland, P., 2016. [Immunological markers of rheumatoid arthritis]. Postepy higieny i medycyny doswiadczalnej (online), 70, 251–257.
   PubMedGoogle Scholar
• Mikuls, T.R., et al., 2018. Malondialdehyde-acetaldehyde antibody concentrations in rheumatoid arthritis and other rheumatic conditions. International immunopharmacology, 56, 113–118.
   PubMed Web of Science ®Google Scholar
• Murata, K., et al., 2013. Comprehensive microRNA analysis identifies miR-24 and miR-125a-5p as plasma biomarkers for rheumatoid arthritis. PloS one, 8 (7), e69118.
   PubMed Web of Science ®Google Scholar
• Murata, K., et al., 2010. Plasma and synovial fluid microRNAs as potential biomarkers of rheumatoid arthritis and osteoarthritis. Arthritis research & therapy, 12 (3), R86.
   PubMed Web of Science ®Google Scholar
• Mydel, P., et al., 2010. Carbamylation-dependent activation of t cells: a novel mechanism in the pathogenesis of autoimmune arthritis. Journal of immunology, 184 (12), 6882–6890.
   PubMed Web of Science ®Google Scholar
• Nakken, B., et al., 2017. Biomarkers for rheumatoid arthritis: from molecular processes to diagnostic applications-current concepts and future perspectives. Immunology letters, 189, 13–18.
   PubMed Web of Science ®Google Scholar
• Nienhuis, R.L.F., Mandema, E., and Smids, C., 1964. A new serum factor in patients with rheumatoid arthritis: the antiperinuclear factor. Annals of the rheumatic diseases, 23, 302–305.
   PubMed Web of Science ®Google Scholar
• Nissim, A., et al., 2005. Generation of neoantigenic epitopes after posttranslational modification of type II collagen by factors present within the inflamed joint. Arthritis and rheumatism, 52 (12), 3829–3838.
   PubMedGoogle Scholar
• Okada, Y., et al., 2019. Genetics of rheumatoid arthritis: 2018 status. Annals of the rheumatic diseases, 78 (4), 446–453.
   PubMed Web of Science ®Google Scholar
• Ospelt, C., et al., 2017. Carbamylation of vimentin is inducible by smoking and represents an independent autoantigen in rheumatoid arthritis. Annals of the rheumatic diseases, 76 (7), 1176–1183.
   PubMed Web of Science ®Google Scholar
• Panayi, G.S., 2005. B cells: a fundamental role in the pathogenesis of rheumatoid arthritis? Rheumatology, 44 (Suppl 2), ii3–ii7.
   PubMed Web of Science ®Google Scholar
• Papayannopoulos, V., and Zychlinsky, A., 2009. NETs: a new strategy for using old weapons. Trends in immunology, 30 (11), 513–521.
   PubMed Web of Science ®Google Scholar
• Pratesi, F., et al., 2014. Antibodies from patients with rheumatoid arthritis target citrullinated histone 4 contained in neutrophils extracellular traps. Annals of the rheumatic diseases, 73 (7), 1414–1422.
   PubMed Web of Science ®Google Scholar
• Raychaudhuri, S., et al., 2012. Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritis. Nature genetics, 44 (3), 291–296.
   PubMed Web of Science ®Google Scholar
• Regueiro, C., et al., 2017. Value of measuring anti-carbamylated protein antibodies for classification on early arthritis patients. Scientific reports, 7 (1), 12023.
   PubMedGoogle Scholar
• Reyes-Castillo, Z., et al., 2015. Comparative analysis of autoantibodies targeting peptidylarginine deiminase type 4, mutated citrullinated vimentin and cyclic citrullinated peptides in rheumatoid arthritis: associations with cytokine profiles, clinical and genetic features. Clinical and experimental immunology, 182 (2), 119–131.
   PubMed Web of Science ®Google Scholar
• Rieck, M., et al., 2007. Genetic variation in PTPN22 corresponds to altered function of T and B lymphocytes. Journal of immunology), 179 (7), 4704–4710.
   PubMed Web of Science ®Google Scholar
• Rigby, W.F.C., et al., 2017. Anti-citrullinated protein antibody, anti-carbamylated protein antibody, and rheumatoid arthritis: azurophilic granules sing the blues. Arthritis & rheumatology, 69 (12), 2251–2255.
   PubMed Web of Science ®Google Scholar
• Sandhu, J.K., et al., 2003. Distribution of protein nitrotyrosine in synovial tissues of patients with rheumatoid arthritis and osteoarthritis. Journal of rheumatology, 30 (6), 1173–1181.
   PubMed Web of Science ®Google Scholar
• Scinocca, M., et al., 2014. Antihomocitrullinated fibrinogen antibodies are specific to rheumatoid arthritis and frequently bind citrullinated proteins/peptides. Journal of rheumatology, 41 (2), 270–279.
   PubMed Web of Science ®Google Scholar
• Seaman, A., et al., 2016. Anti-peptidyl-arginine deaminase 3 (PAD3) antibodies as a promising marker to measure joint damage in patients with rheumatoid arthritis. Autoimmunity reviews, 15 (7), 776–780.
   PubMed Web of Science ®Google Scholar
• Shi, J., et al., 2011. Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage. Proceedings of the National Academy of Sciences of the United States of America, 108 (42), 17372–17377.
   PubMed Web of Science ®Google Scholar
• Shi, J., et al., 2013. Anti-carbamylated protein antibodies are present in arthralgia patients and predict the development of rheumatoid arthritis. Arthritis and rheumatism, 65 (4), 911–915.
   PubMedGoogle Scholar
• Sokolove, J., et al., 2012. Autoantibody epitope spreading in the pre-clinical phase predicts progression to rheumatoid arthritis. PLoS oNE, 7 (5), e35296.
   PubMed Web of Science ®Google Scholar
• Spengler, J., et al., 2015. Release of active peptidyl arginine deiminases by neutrophils can explain production of extracellular citrullinated autoantigens in rheumatoid arthritis synovial fluid. Arthritis & rheumatology, 67 (12), 3135–3145.
   PubMed Web of Science ®Google Scholar
• Stanford, S.M., and Bottini, N., 2014. PTPN22: the archetypal non-HLA autoimmunity gene. Nature reviews. Rheumatology, 10 (10), 602–611.
   PubMed Web of Science ®Google Scholar
• Strollo, R., et al., 2013. Autoantibodies to post translationally modified type II collagen as potential biomarkers for rheumatoid arthritis. Arthritis & rheumatism, 65 (7), 1702–1712.
   PubMedGoogle Scholar
• Sur Chowdhury, C., et al., 2014. Enhanced neutrophil extracellular trap generation in rheumatoid arthritis: analysis of underlying signal transduction pathways and potential diagnostic utility. Arthritis research & therapy, 16 (3), R122.
   PubMed Web of Science ®Google Scholar
• Tan, E.M., and Smolen, J.S., 2016. Historical observations contributing insights on etiopathogenesis of rheumatoid arthritis and role of rheumatoid factor. Journal of experimental medicine, 213 (10), 1937–1950.
   PubMed Web of Science ®Google Scholar
• Tang, Y., et al., 2017. The role of long non-coding RNAs in rheumatic diseases. Nature reviews. Rheumatology, 13 (11), 657–669.
   PubMed Web of Science ®Google Scholar
• Tilvawala, R., et al., 2018. The rheumatoid arthritis-associated citrullinome. Cell chemical biology, 25 (6), 691–704.e6.
   PubMed Web of Science ®Google Scholar
• Tony, H.-P., et al., 2015. Combination of B cell biomarkers as independent predictors of response in patients with rheumatoid arthritis treated with rituximab. Clinical and experimental rheumatology, 33 (6), 887–894.
   PubMed Web of Science ®Google Scholar
• van Boekel, M.A., et al., 2002. Autoantibody systems in rheumatoid arthritis: specificity, sensitivity and diagnostic value. Arthritis research, 4 (2), 87–93.
   PubMedGoogle Scholar
• van der Woude, D., et al., 2009. Quantitative heritability of anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis. Arthritis and rheumatism, 60 (4), 916–923.
   PubMed Web of Science ®Google Scholar
• van El, C.G., et al., 2013. Whole-genome sequencing in health care: recommendations of the European Society of Human Genetics. European journal of human genetics, 21 (6), 580–584.
   PubMed Web of Science ®Google Scholar
• Vang, T., et al., 2005. Autoimmune-associated lymphoid tyrosine phosphatase is a gain-of-function variant. Nature genetics, 37 (12), 1317–1319.
   PubMed Web of Science ®Google Scholar
• Vang, T., et al., 2013. The autoimmune-predisposing variant of lymphoid tyrosine phosphatase favors T helper 1 responses. Human immunology, 74 (5), 574–585.
   PubMed Web of Science ®Google Scholar
• van Venrooij, W.J., et al., 2011. Anti-CCP antibodies: the past, the present and the future. Nature reviews. Rheumatology, 7 (7), 391–398.
   PubMed Web of Science ®Google Scholar
• Vergroesen, R.D., et al., 2018. B-cell receptor sequencing of anti-citrullinated protein antibody (ACPA) IgG-expressing B cells indicates a selective advantage for the introduction of N-glycosylation sites during somatic hypermutation. Annals of the rheumatic diseases, 77 (6), 956–958.
   PubMed Web of Science ®Google Scholar
• Volkov, M., van Schie, K.A., and van der Woude, D., 2019. Autoantibodies and B cells: the ABC of rheumatoid arthritis pathophysiology. Immunological reviews, 294 (1), 148–163.
   PubMed Web of Science ®Google Scholar
• Waaler, E., 2009. On the occurrence of a factor in human serum activating the specific agglutination of sheep blood corpuscles. Acta pathologica microbiologica scandinavica, 17 (2), 172–188.
   Google Scholar
• Wang, Y., et al., 2015. PTPN22 variant R620W is associated with reduced toll-like receptor 7-induced type i interferon in systemic lupus erythematosus. Arthritis & rheumatology, 67 (9), 2403–2414.,
   PubMed Web of Science ®Google Scholar
• Winyard, P.G., et al., 2011. Measurement and meaning of markers of reactive species of oxygen, nitrogen and sulfur in healthy human subjects and patients with inflammatory joint disease. Biochemical society transactions, 39 (5), 1226–1232.
   PubMed Web of Science ®Google Scholar
• Wynn, T.A., 2019. Two types of fibroblast drive arthritis. Nature, 570 (7760), 169–170.
   PubMed Web of Science ®Google Scholar
• Xu, D., et al., 2017. Long noncoding RNAs expression profile and functional networks in rheumatoid arthritis. Oncotarget, 8 (56), 95280–95292.
   PubMedGoogle Scholar
• Yang, X., et al., 2016. Diagnostic accuracy of anti-RA33 antibody for rheumatoid arthritis: systematic review and meta-analysis. Clinical and experimental rheumatology, 34 (3), 539–547.
   PubMed Web of Science ®Google Scholar
• Yee, A., et al., 2015. Anti-CarP antibodies as promising marker to measure joint damage and disease activity in patients with rheumatoid arthritis. Immunologic research, 61 (1-2), 24–30.
   PubMed Web of Science ®Google Scholar
• Zhang, Y., et al., 2016. Long noncoding RNA expression profile in fibroblast-like synoviocytes from patients with rheumatoid arthritis. Arthritis research & therapy, 18 (1), 227.
   PubMedGoogle Scholar
• Zheng, J., et al., 2012. Meta-analysis reveals an association of PTPN22 C1858T with autoimmune diseases, which depends on the localization of the affected tissue. Genes and immunity, 13 (8), 641–652.
   PubMed Web of Science ®Google Scholar